首页> 外文期刊>Cell biochemistry and biophysics >Risk Evaluation of Selective Renal Arterial Embolization in the Treatment of Delayed Hemorrhage from Renal Artery Pseudoaneurysm After Partial Nephrectomy
【24h】

Risk Evaluation of Selective Renal Arterial Embolization in the Treatment of Delayed Hemorrhage from Renal Artery Pseudoaneurysm After Partial Nephrectomy

机译:选择性肾动脉栓塞治疗部分肾切除术后肾动脉假性动脉瘤延迟出血的风险评估

获取原文
获取原文并翻译 | 示例
           

摘要

Renal-artery pseudoaneurysm (RAP) is a well-described complication of partial nephrectomy. We aimed to evaluate the occurrence rate of delayed hemorrhage from RAP after partial nephrectomy, and to investigate the efficacy and safety of selective renal arterial embolization. Between January 2000 and December 2010, 426 partial nephrectomies were performed at our institution for treatment of small renal mass (SRMs). A retrospective review of these cases revealed that 14 patients developed a postoperative RAP (3.29 % incidence). We compared the clinical characteristics between the 14 patients with delayed renal hemorrhage and other 412 patients. RAP was diagnosed by renal angiography in 12 patients with delayed renal hemorrhage. Of the 12 patients, 10 patients were successfully treated with selective renal arterial embolization after presenting with symptoms postoperatively, 1 patient was treated with open surgery, and 1 patient was treated with nephrectomy. The other two patients showed no abnormalities in renal angiography, and the symptoms relieved by transfusion and hemostasis treatment. We found that tumor type, tumor size, tumor location, and surgical approach were significantly different between the 14 patients and other 412 patients. RAP showed a low incidence. The risk factors of RAP included renal cell carcinoma, tumor with large size, and tumor location. Most patients with delayed renal hemorrhage from RAP were successfully cured by selective renal arterial embolization. Therefore, selective renal arterial embolization can be used as the preferential therapy for RAP.
机译:肾动脉假性动脉瘤(RAP)是肾部分切除术的一种描述良好的并发症。我们的目的是评估部分肾切除术后RAP延迟出血的发生率,并研究选择性肾动脉栓塞的疗效和安全性。在2000年1月至2010年12月之间,在我们的机构进行了426次部分性肾切除术,以治疗小肾脏肿块(SRM)。对这些病例的回顾性研究显示,有14例患者发生了术后RAP(发生率3.29%)。我们比较了14例延迟性肾出血患者和其他412例患者的临床特征。通过肾血管造影诊断为RAP的12例延迟性肾出血患者。 12例患者中,有10例在术后出现症状后成功接受了选择性肾动脉栓塞治疗,1例接受了开放手术治疗,1例接受了肾切除术治疗。另外两名患者的肾血管造影未见异常,经输血和止血治疗可缓解症状。我们发现14例患者与其他412例患者的肿瘤类型,肿瘤大小,肿瘤位置和手术方式显着不同。 RAP的发生率很低。 RAP的危险因素包括肾细胞癌,大尺寸肿瘤和肿瘤位置。 RAP延迟性肾出血的大多数患者可通过选择性肾动脉栓塞术成功治愈。因此,选择性肾动脉栓塞术可作为RAP的首选疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号